"Hepatitis B, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Descriptor ID |
D019694
|
| MeSH Number(s) |
C02.256.430.400.100 C02.440.435.100 C06.552.380.350.100 C06.552.380.705.437.100
|
| Concept/Terms |
Hepatitis B, Chronic- Hepatitis B, Chronic
- Chronic Hepatitis B
- Hepatitis B Virus Infection, Chronic
- Chronic Hepatitis B Virus Infection
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B, Chronic".
This graph shows the total number of publications written about "Hepatitis B, Chronic" by people in this website by year, and whether "Hepatitis B, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 3 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 0 | 4 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 2 | 3 |
| 2010 | 4 | 1 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 7 | 0 | 7 |
| 2016 | 4 | 0 | 4 |
| 2017 | 5 | 1 | 6 |
| 2018 | 8 | 3 | 11 |
| 2019 | 4 | 1 | 5 |
| 2020 | 6 | 0 | 6 |
| 2021 | 2 | 1 | 3 |
| 2022 | 6 | 0 | 6 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B, Chronic" by people in Profiles.
-
National Liver Cancer Screening Trial (TRACER) study protocol. Hepatol Commun. 2024 Nov 01; 8(11).
-
Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
-
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204. Support Care Cancer. 2022 Dec 31; 31(1):93.
-
Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2/S promoter activity. Antiviral Res. 2022 12; 208:105448.
-
Detecting Early Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Using Longitudinal a-Fetoprotein Screening. Clin Gastroenterol Hepatol. 2023 06; 21(6):1590-1597.
-
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol. 2022 11; 32(6):e2353.
-
Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clin Microbiol Infect. 2022 Oct; 28(10):1321-1327.
-
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. Clin Gastroenterol Hepatol. 2023 04; 21(4):1111-1113.e3.
-
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19. Hepatology. 2021 10; 74(4):1750-1765.
-
Hepatocellular Carcinoma in Sub-Saharan Africa. JCO Glob Oncol. 2021 05; 7:756-766.